Revenue: As of FY2025 Q1, the actual value is USD 15.17 M, missing the estimate of USD 19.3 M.

EPS: As of FY2025 Q1, the actual value is USD -0.1, missing the estimate of USD -0.07.

EBIT: As of FY2025 Q1, the actual value is USD -4.931 M.

Segment Revenue

• Total Revenue: $15.2 million for the three months ended March 31, 2025, compared to $23.2 million for the same period in 2024, representing a decrease of 34.7%.
• Services Revenue: $4.9 million for the three months ended March 31, 2025, compared to $5.3 million for the same period in 2024.
• Wellness Revenue: $9.2 million for the three months ended March 31, 2025, compared to $15.8 million for the same period in 2024.
• Pet Food & Treats Revenue: $1.1 million for the three months ended March 31, 2025, compared to $2.1 million for the same period in 2024.

Operational Metrics

• Net Loss: $4.9 million for the three months ended March 31, 2025, compared to $4.2 million for the same period in 2024, an increase of 15.3%.
• Net Loss Margin: -32.2% for the three months ended March 31, 2025, compared to -18.3% for the same period in 2024.
• Total Costs and Expenses: $18.9 million for the three months ended March 31, 2025, compared to $25.0 million for the same period in 2024, a decrease of 24.2%.

Cash Flow

• Net Cash Provided by Operating Activities: $1.4 million for the three months ended March 31, 2025, compared to $0.2 million for the same period in 2024.
• Net Cash Used in Investing Activities: -$0.4 million for the three months ended March 31, 2025, compared to -$0.3 million for the same period in 2024.
• Net Cash Used in Financing Activities: -$0.5 million for the three months ended March 31, 2025, compared to -$5.6 million for the same period in 2024.

Future Outlook and Strategy

• Core Business Focus: The company is actively engaged in discussions to refinance the existing Financing Agreement and is exploring strategic alternatives such as potential investments, strategic partnerships, sale, merger, or other strategic transactions involving the company or its assets.
• Non-Core Business: The company is conducting a review of strategic alternatives, including potential investments, strategic partnerships, sale, merger, or other strategic transactions involving its assets.

Unique Metrics

• Adjusted EBITDA (Loss): -$1.2 million for the three months ended March 31, 2025, compared to $0.2 million for the same period in 2024.